Inmune Bio, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
INMB on Nasdaq
Location
225 Ne Mizner Blvd, Suite 640, Boca Raton, FL

There are no Buy or Sell transactions made by insiders since 10/10/2024

Inmune Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Xencor Inc 10%+ Owner $13.1M Sep 3, 2021
Mark William Lowdell Chief Scientific Officer, 10%+ Owner $12.6M Dec 5, 2024
Raymond Joseph Tesi President and CEO, Director, 10%+ Owner $9.91M Dec 5, 2024
David Moss Chief Financial Officer, 10%+ Owner $6.8M Dec 5, 2024
Scott Juda Director $521K Dec 5, 2024
Edgardo Baracchini Jr Director May 14, 2024
James Kelly Ganjei Director Dec 5, 2024
Cory Randall Ellspermann Interim CFO Aug 4, 2025
Timothy Schroeder Director Dec 5, 2024
Marcia Allen Director Dec 5, 2024

Recent Insider Transactions by Companies or Individuals for Inmune Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.